Association of the neoadjuvant chemotherapy cycle with survival outcomes in patients with locoregionally advanced nasopharyngeal carcinoma: a propensity-matched analysis

Neoadjuvant chemotherapy (NAC) is widely used to treat locoregionally advanced nasopharyngeal carcinoma (NPC). To determine the optimal number of NAC cycles, we assessed the effect of NAC cycle on survival outcomes of locoregionally advanced NPC patients receiving NAC before concurrent chemotherapy...

Descripción completa

Detalles Bibliográficos
Autores principales: Fangzheng, Wang, Chuner, Jiang, Zhimin, Ye, Quanquan, Sun, Tongxin, Liu, Min, Xu, Peng, Wu, Bin, Long, Sakamoto, Masoto, Yuezhen, Wang, Fengqin, Yan, Zhenfu, Fu, Yangming, Jiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706860/
https://www.ncbi.nlm.nih.gov/pubmed/29212214
http://dx.doi.org/10.18632/oncotarget.21587

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5706860/
https://www.ncbi.nlm.nih.gov/pubmed/29212214
http://dx.doi.org/10.18632/oncotarget.21587

Ejemplares similares